Myricetin, a common dietary
flavonoid, is widely distributed in fruits and vegetables and is used as a health food supplement based on its anti-
tumor properties. However, the effect and mechanisms of
myricetin in esophageal
carcinoma are not fully understood. Here, we demonstrated the effect of
myricetin on the proliferation, apoptosis, and invasion of the esophageal
carcinoma cell lines EC9706 and KYSE30 and explored the underlying mechanism and target
protein(s) of
myricetin.
CCK-8 assay, transwell invasion assay, wound-healing assay, cell cycle analysis, and apoptosis assay were used to evaluate the effects of
myricetin on cell proliferation, invasion, and apoptosis. Nude mouse
tumor xenograft model was built to understand the interaction between
myricetin and NTD RSK2. Pull-down assay was used to verify molecular mechanism.
Myricetin inhibited proliferation and invasion and induced apoptosis of EC9706 and KYSE30 cells. Moreover,
myricetin was shown to bind RSK2 through the NH2-terminal
kinase domain. Finally,
myricetin inhibited EC9706 and KYSE30 cell proliferation through Mad1 and induced cell apoptosis via Bad.
Myricetin inhibits the proliferation and invasion and induces apoptosis in EC9706 and KYSE30 cells via RSK2.
Myricetin exerts anti-proliferative, anti-invasive, and pro-apoptotic effects on esophageal
carcinoma EC9706 and KYSE30 cells via RSK2. Our results provide novel insight into
myricetin as a potential agent for the prevention and treatment of esophageal
carcinoma.